(The Epoch Times)—Receiving blood transfusion from COVID-19-vaccinated individuals could pose a medical risk to unvaccinated recipients since numerous adverse events are being reported among vaccinated people worldwide, according to a recent study from Japan.
The preprint review, published on March 15, examined whether receiving blood from COVID-19-vaccinated individuals is safe or poses a health risk. Many nations have reported that mRNA vaccine usage has resulted in “post-vaccination thrombosis and subsequent cardiovascular damage, as well as a wide variety of diseases involving all organs and systems, including the nervous system,” it said.
Repeated vaccinations can make people more vulnerable to COVID-19, it said. If the blood contains spike proteins, it becomes necessary to remove these proteins prior to administration, and there is no such technology currently available, the authors wrote.
Contrary to earlier expectations, genes and proteins from genetic vaccines have been found to persist in the blood of vaccine recipients for “prolonged periods of time.”
In addition, “a variety of adverse events resulting from genetic vaccines are now being reported worldwide.” This includes a wide range of diseases related to blood and blood vessels.
Some studies have reported that the spike protein in the mRNA vaccines is neurotoxic and capable of crossing the blood-brain barrier, the review stated. “Thus, there is no longer any doubt that the spike protein used as an antigen in genetic vaccines is itself toxic.”
Moreover, people who have taken multiple shots of mRNA vaccines can have several exposures to the same antigen within a small time frame, which may lead to them being “imprinted with a preferential immune response to that antigen.”
This has resulted in COVID-19 vaccine recipients becoming “more susceptible to contracting COVID-19.”
JD’s manually curated links for God-fearing MAGA patriots
Given such concerns, medical professionals should be aware of the “various risks associated with blood transfusions using blood products derived from people who have suffered from long COVID and from genetic vaccine recipients, including those who have received mRNA vaccines.”
The impact of such genetic vaccines on blood products as well as the actual damage caused by them are currently unknown, the authors wrote.
“In order to avoid these risks and prevent further expansion of blood contamination and complication of the situation, we strongly request that the vaccination campaign using genetic vaccines be suspended and that a harm–benefit assessment be carried out as early as possible.”
Repeated vaccination of genetic vaccines can also end up causing “alterations in immune function” among recipients. This raises the risk of serious illnesses due to opportunistic infections or pathogenic viruses, which would not have been an issue if the immune system were normal, the review said.
“Therefore, from the perspective of traditional containment of infectious diseases, greater caution is required in the collection of blood from genetic vaccine recipients and the subsequent handling of blood products, as well as during solid organ transplantation and even surgical procedures in order to avoid the risk of accidental blood-borne infection,” it stated.
The review was funded by members of the Japanese Society for Vaccine-related Complications and the Volunteer Medical Association. Authors did not declare any conflict of interest.
Dangers With Blood Transfusions
The review pointed out that the genetic vaccination status of blood donors is not collected by organizations even though the use of such blood may pose risks to patients. As such, authors recommended that when blood products are derived from such people, “it is necessary to confirm the presence or absence of spike protein or modified mRNA as in other tests for pathogens.”
“If the blood product is found to contain the spike protein or a modified gene derived from the genetic vaccine, it is essential to remove them,” it stated. “However, there is currently no reliable way to do so.”
Since “there is no way to reliably remove the pathogenic protein or mRNA, we suggest that all such blood products be discarded until a definitive solution is found.”
The authors pointed out that cases of encephalitis among people who received blood from dengue vaccine recipients were reported as recently as last year. This suggests that the present system of tracking and managing blood products “is not adequate.”
Since genetic vaccines were implemented on a global scale for a massive population, “it is expected that the situation will already be complicated” compared to previous drug disasters.
As such, there is an “urgent need” for legislation and international treaties related to the management of blood products, the authors wrote.
The issue of blood transfusion from COVID-19 vaccine recipients has been highly controversial. In 2022, a court in New Zealand ruled against the parents of a sick infant son after they refused blood transfusions from vaccinated people.
The parents had asked the health system to allow blood transfusion from unvaccinated individuals, with donors who were already prepared to contribute. In its ruling, the court stripped the parents of medical custody of their son.
In Canada, doctors have also reported the trend of people’s resistance to vaccinated blood transfusions. Speaking to CBC in 2022, Dr. Dave Sidhu, the southern Alberta medical lead for transfusion and transplant medicine, said that parents of sick children were requesting unvaccinated blood.
“We’re seeing it about once or twice a month, at this stage. And the worry is of course that these requests might increase,” he said at the time.
In Wyoming, Rep. Sarah Penn (R-Wyo.) has sponsored a bill mandating that blood donated by people who have taken COVID-19 shots be labeled. Doing so will allow recipients who do not wish to accept such blood to reject them.
In an interview with Cowboy State Daily, Ms. Penn said, “For various reasons, many people have purposefully strived to keep the mRNA therapies out of their bodies, even to the point that some lost their livelihoods … Their concerns are warranted.”
Bypass Big Tech Censors
Why Bullion Beats Numismatics and Collectible for Your Safe or IRA
Precious metals continue to attract Americans seeking reliable ways to protect their wealth amid inflation, geopolitical risks, and stock market swings. Whether stored in a home safe or held inside a self-directed IRA, physical gold and silver deliver tangible value that paper or digital assets often lack. Yet investors must choose carefully between bullion—pure bars and coins valued mainly for their metal content—and numismatics or collectibles, where rarity, history, and collector demand heavily influence pricing.
Advisor Bullion serves as a dependable source for straightforward, high-quality bullion. The company specializes in physical gold, silver, platinum, and palladium, emphasizing transparent pricing and products that deliver maximum metal content for every dollar spent. This approach makes it ideal for both personal holdings and retirement accounts.
Bullion consists of refined precious metals in standard forms like one-ounce coins (American Gold Eagles, Silver Eagles, Canadian Maple Leafs) or bars. Their value tracks closely to the current spot price of the metal. A typical gold bullion coin trades near the live gold spot price plus a small premium. This structure keeps costs clear and predictable.
Numismatic coins and collectibles add substantial value from factors such as age, rarity, minting errors, or historical significance. A pre-1933 U.S. gold coin or graded proof piece can carry premiums of 30%, 50%, or even 200% above melt value. While this appeals to hobbyists, it creates complexity. Pricing depends on subjective grading, collector trends, and auction results instead of daily spot prices.
For investors focused on wealth preservation and retirement security rather than building a collection, bullion often delivers better results.
Lower Costs and Better Liquidity for Home Storage
When keeping metals in a home safe or private vault, liquidity and efficiency count. Bullion offers clear benefits:
- You acquire more actual gold or silver per dollar invested. Numismatics divert a large share of your money into rarity premiums and massive sales commission, reducing your metal exposure.
- Selling bullion involves tight bid-ask spreads, so you recover nearly full spot value with minimal fees. Collectibles require finding the right buyer and may sell at a discount if demand for that specific item weakens.
- Bullion prices remain transparent and update with global spot markets. You can track gold near current levels or silver accordingly and know exactly where your holdings stand. Numismatic values are priced by the Gold IRA companies with hefty margins applied.
- Standardized coins and bars store efficiently and divide easily for partial sales. Rare coins often need protective slabs and controlled conditions, adding hassle and expense.
- Bullion enjoys worldwide acceptance. A 1-oz Gold Maple Leaf or Silver Eagle sells quickly to dealers anywhere. Niche numismatic pieces may appeal only to limited buyers, slowing liquidation when speed matters.
In times when quick access to value becomes important, bullion’s simplicity stands out.
Stronger Fit for Precious Metals IRAs
Precious metals IRAs continue gaining traction as investors diversify retirement portfolios beyond stocks and bonds. IRS rules permit certain bullion products in self-directed IRAs if they meet purity standards (.995 fine for gold, .999 for silver) and are held by an approved custodian. Eligible items include American Gold and Silver Eagles plus many generic bars and rounds from recognized mints.
Numismatic and most collectible coins generally face heavy scrutiny from custodians due to valuation disputes and elevated markups. These higher premiums mean less actual metal ends up working inside the account.
Bullion avoids these issues. Its value links directly to verifiable spot prices, which simplifies reporting and lowers the risk of regulatory challenges. More of your IRA contribution purchases real metal instead of dealer profits or speculative upside. Over time, owning additional ounces that appreciate with the metal itself can create meaningful outperformance compared with high-premium alternatives that deliver fewer ounces.
Regulatory guidance from the CFTC and state securities offices repeatedly cautions against aggressive sales of expensive numismatics or “semi-numismatic” coins for IRAs. For retirement planning, transparent bullion from established providers reduces risk and aligns better with long-term goals.
How to Get Started with Bullion
Begin by clarifying your goals. Are you protecting savings in a safe, or moving part of a retirement account into a precious metals IRA? Focus on the number of ounces you can acquire at current prices rather than chasing marked-up collectibles.
Diversify sensibly: use gold for core preservation and silver for its blend of industrial and monetary qualities. Mix coins for easier divisibility with bars for lower per-ounce costs on larger buys. Arrange secure storage—whether at home with proper insurance or through professional facilities.
As economic uncertainties linger and faith in conventional assets erodes, bullion continues proving its worth as a dependable store of value. Its direct approach avoids the hype that sometimes surrounds collectible markets and keeps the focus on the metal itself.
For investors prepared to strengthen their portfolios, Advisor Bullion supplies the expertise and selection needed to acquire high-quality bullion efficiently. Whether building personal holdings or integrating metals into an IRA, their emphasis on transparent, investment-grade products helps secure more ounces today that support greater financial security tomorrow. In a complicated financial landscape, bullion’s clarity and reliability make it the smarter foundation for protecting what matters most.